搜索结果: 1-15 共查到“肿瘤学 clinical”相关记录51条 . 查询时间(0.126 秒)
近日，解放军总医院肿瘤医学部生物治疗科主任韩为东/聂晶团队与军事医学研究院伯晓晨/陈河兵团队在《JournalofClinicalInvestigation》期刊（影响因子19.456）合作发表论文，阐明DNA去甲基化药物地西他滨增强PD-1抑制剂抗瘤效能的分子与细胞学机制。
暨南大学基础医学院张灏团队在Clinical Cancer Research上发表研究成果（图）
暨南大学基础医学院 张灏 Clinical Cancer Research 肿瘤免疫
2020/9/2
2020年7月9日，暨南大学基础医学院张灏团队在美国癌症学会杂志Clinical Cancer Research上报告了世界上第一个应用二甲双胍治疗食管鳞癌的临床试验。该研究表明糖尿病药物二甲双胍在杀伤病人肿瘤细胞之前，已经对肿瘤免疫微环境进行了重编程改造。在临床试验的基础上，课题组通过食管癌小鼠模型进行了更详细的验证和延伸，并结合细胞实验对二甲双胍编程免疫微环境的机制进行了探讨。
近日，我校肿瘤干细胞研究院刘强教授课题组取得重要研究进展，在国际医学领域权威期刊《Journal of Clinical Investigation》（《临床调查》）上发表论文“Stress-induced epinephrine enhances lactate dehydrogenase A promoting breast cancer stem-like cell”（《压力诱导的肾上腺素增...
首都医科大学附属北京世纪坛医院任军教授团队《Clinical Cancer Research》阐述化疗联合细胞免疫治疗可改善晚期胃癌预后（图）
首都医科大学附属北京世纪坛医院 任军 教授 细胞免疫治疗 晚期胃癌预后
2019/3/14
近期，首都医科大学附属北京世纪坛医院任军教授团队在《Clinical Cancer Research》(5年IF:9.697)上发表题为"Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gas...
中国药科大学药物科学研究院杨勇教授团队在学术期刊Clinical Cancer Research发文揭秘抑郁影响肿瘤免疫微环境新机制（图）
中国药科大学药物科学研究院 杨勇 教授 学术期刊 Clinical Cancer Research 抑郁 肿瘤免疫 微环境 新机制
2019/4/1
近日，中国药科大学药物科学研究院的杨勇教授团队在学术期刊Clinical Cancer Research（IF 10.199）发表最新研究成果，Depression induced neuropeptide Y secretion promotes prostate cancer growth by recruiting myeloid cells（pp.clincanres-2912），阐明抑郁...
中山大学附属第一医院柯尊富主任医师团队在Clinical Cancer Research期刊发表驱动基因阴性肺腺癌研究成果（图）
中山大学附属第一医院 柯尊富 主任医师 驱动基因 阴性 肺腺癌 研究成果
2018/12/4
2018年11月3日，我校附属第一医院病理科柯尊富主任医师肺癌研究团队在Clinical Cancer Research (IF 2017=10.19）期刊上发表了研究性论文Development and validation of a novel signature to predict overall survival in “driver-gene-negative” lung adenoc...
中山大学肿瘤防治中心傅剑华、刘孟忠教授牵头的NEOCRTEC 5010研究成果在国际顶尖杂志《Journal of Clinical Oncology》发表（图）
中山大学肿瘤防治中心 傅剑华 刘孟忠 教授 NEOCRTEC 5010 国际顶尖杂志 Journal of Clinical Oncology
2018/9/21
受中山大学“5010”项目基金及卫生部部属医院临床学科重点项目基金资助，由我校肿瘤防治中心傅剑华、刘孟忠教授牵头的NEOCRTEC5010研究——新辅助放化疗并手术治疗局部晚期食管鳞癌的III期临床试验阶段性研究成果于2018年8月9日正式发表于Journal of Clinical Oncology（《临床肿瘤学杂志》，以下简称JCO）（IF26.3）。这也是JCO创刊以来，首次由中国医生主导完...
上海中医药大学科研团队在国际著名医学期刊《Journal of Clinical Investigation》发表最新研究成果（图）
上海中医药大学 科研团队 国际著名医学期刊 Journal of Clinical Investigation 研究成果 肿瘤基因组 大数据分析
2018/5/7
近期，我校脾胃病研究所在肿瘤基因组大数据分析以及精准治疗的设计研究中取得重要突破，研究成果“Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer”（利用粘连蛋白体基因突变设计的癌症治疗）在2018年4月在线发表于国际著名医学期刊《Journal of Clinica...
2017冷泉港学术会议:基础和临床癌症研究的重要性（Cold Spring Harbor conference on Importance in Basic & Clinical Cancer Research）
Interferon inflammation
2017/1/16
We are pleased to announce a new Cold Spring Harbor winter conference on STATs: Importance in Basic & Clinical Cancer Research, which will begin at 7:30 pm on Wednesday, November 15 and run through lu...
Ethical issues around phase I and phase III clinical trials in cancer
Cancer clinical trials clinical practice drug toxicity
2017/2/22
The results of phase III (randomised) cancer clinical trials underpin evidence-based clinical practice. A standard comparator (control arm) is crucial so that the real value of an intervention can be ...
Expression and Clinical Significance of Tumor Necrosis Factor Receptor-Associated Factor 6 in Patients With Colon Cancer
Receptors Tumor Necrosis Factor Gene Expression Colonic Neoplasms
2016/1/26
Background: Tumor necrosis factor receptor-associated factor 6 (TRAF6) has been reported to be highly expressed in many tumor tissues, but it is still of value to detect its expression in patients wit...
An Organizational Informatics Analysis of Colorectal, Breast, and Cervical Cancer Screening Clinical Decision Support and Information Systems within Community Health Centers
community health centers clinical decision support network analysis
2015/5/26
A study design has been developed that employs a dual modeling approach to identify factors associated with facility-level cancer screening improvement and how this is mediated by the use of clinical ...
CORRELATING IRINOTECAN AND CAPECITABINE TREATMENT FOR COLORECTAL CANCER TO GENE EXPRESSION, POLYMORPHISMS, AND CLINICAL OUTCOMES
Irinotecan CPT-11 Capecitabine
2015/5/25
Colorectal cancer is the third most common type of cancer and the third most common cause of cancer-related mortality. There are three types of treatment available to patients, either individually or ...
Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer
PSA testing early management test-detected prostate cancer
2015/4/17
There is a consensus among relevant peak professional bodies, government and non-government organisations in Australia, that Australian clinical practice guidelines for prostate specific antigen (PSA)...
Survival after breast cancer diagnosis and treatment has improved markedly, however recurrence is still a treatment challenge for clinicians. The underlying cause for late recurrence after a long dise...